These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 27735788)

  • 1. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
    Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
    Elife; 2016 Oct; 5():. PubMed ID: 27735788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARM1 is a metabolic sensor activated by an increased NMN/NAD
    Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
    Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
    Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
    Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
    Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
    Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
    Ko KW; Milbrandt J; DiAntonio A
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemical biology of NAD
    Icso JD; Thompson PR
    Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
    Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
    Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration.
    Sasaki Y; Kakita H; Kubota S; Sene A; Lee TJ; Ban N; Dong Z; Lin JB; Boye SL; DiAntonio A; Boye SE; Apte RS; Milbrandt J
    Elife; 2020 Oct; 9():. PubMed ID: 33107823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.
    McGuinness HY; Gu W; Shi Y; Kobe B; Ve T
    Neuroscientist; 2024 Aug; 30(4):473-492. PubMed ID: 37002660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly.
    Neukomm LJ; Burdett TC; Seeds AM; Hampel S; Coutinho-Budd JC; Farley JE; Wong J; Karadeniz YB; Osterloh JM; Sheehan AE; Freeman MR
    Neuron; 2017 Jul; 95(1):78-91.e5. PubMed ID: 28683272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
    Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
    Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
    Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD
    Essuman K; Summers DW; Sasaki Y; Mao X; DiAntonio A; Milbrandt J
    Neuron; 2017 Mar; 93(6):1334-1343.e5. PubMed ID: 28334607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
    Summers DW; Gibson DA; DiAntonio A; Milbrandt J
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage depletion blocks congenital SARM1-dependent neuropathy.
    Dingwall CB; Strickland A; Yum SW; Yim AK; Zhu J; Wang PL; Yamada Y; Schmidt RE; Sasaki Y; Bloom AJ; DiAntonio A; Milbrandt J
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36287209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A local mechanism mediates NAD-dependent protection of axon degeneration.
    Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
    J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
    Gerdts J; Summers DW; Milbrandt J; DiAntonio A
    Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NAD
    Llobet Rosell A; Paglione M; Gilley J; Kocia M; Perillo G; Gasparrini M; Cialabrini L; Raffaelli N; Angeletti C; Orsomando G; Wu PH; Coleman MP; Loreto A; Neukomm LJ
    Elife; 2022 Dec; 11():. PubMed ID: 36476387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.